Edison Partners has exited its investment in Jersey City-based clinical trial services company TrialScope, it announced this week.
Read more from ROI-NJ:
The Princeton-based investment firm saw a 3X return on investment, it said in a news release.
Edison Partners noted that, during its investment period, TrialScope has achieved such milestones as partnering with Informa, a biopharma analytics and insights company, and launching TrialScope Connect, which supported recruiting efforts for Moderna’s COVID-19 vaccine.
